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A new approach for turn-on fluorescence sensing
of L-DOPA†
Lu Wang, ‡a Dongdong Su,‡a Stuart N. Berry,ab Jungyeol Leec and
Young-Tae Chang *acd
A novel design strategy for the fluorescence sensing of L-DOPA is
reported. Resa-Sulf displays a significant turn-on fluorescence response
to L-DOPA due to its reduction properties; this sensing mechanism was
fully confirmed by mechanistic studies. Furthermore, Resa-Sulf was
successfully utilized to quantitatively detect L-DOPAconcentrations from
a commercially available source.
Dopamine is known as an important neurotransmitter of the human
central nervous system and aﬀects many brain functions and
behavioral responses.1,2 Lack of dopamine in the brain may lead
to neurological disorders, such as schizophrenia and Parkinson’s
disease. The precursor to dopamine, L-DOPA is converted to
dopamine via a metabolic pathway and, unlike dopamine,
L-DOPA has the ability to cross the protective blood–brain
barrier. This has allowed the external use of L-DOPA therapeutically
to increase dopamine concentrations in the brain. Indeed, L-DOPA
is successfully utilized as a drug in the treatment of Parkinson’s
disease and dopamine-responsive dystonia.3–5 Considering the
biochemical significance of L-DOPA and its applications in the
field of medicine, it is highly desirable to develop an efficient
method for the quantitative detection of L-DOPA. Most reported
methods for L-DOPA detection have mainly been restricted to the
electrochemical study through the use of electrodes composed of
nanorods, nanotubes or graphene nanohybrids.6–9 Compared to
other analytical technology, fluorescent molecular sensors aremore
attractive, due to their high sensitivity and ease of visibility.10,11
Up to now, only limited numbers of small molecule fluorescent
sensors for L-DOPA have been reported.12–14 Furthermore, most
of these small molecule sensors rely on quenching or turn-off
sensing mechanisms. It is known that turn-on sensors have
comparatively better sensitivity, higher resolution as well as
lower potential errors than turn-off sensors. A good turn-on
sensor, therefore, may have unique potential for the future real-
time in vivo or ex vivo imaging of L-DOPA.
Herein, we have demonstrated a new approach for turn-on
fluorescence sensing of L-DOPA by using its reduction properties.
The tendency of L-DOPA to donate an electron in solution can be
exploited by using it as a reductant in a redox reaction and based
on this, we sought to develop a redox reaction based turn-on
fluorescence sensor for L-DOPA.15,16 The major advantage of
redox reaction sensing is that the molecular recognition events
can occur in a short time span, with observable changes in color
and/or fluorescence intensity. Furthermore, quantitative detec-
tion can be easily achieved because of the stoichiometric nature
of the redox reaction. Up to now, according to the selected redox
reaction system, several examples based on redox reactions have
been developed for appropriate applications.17–20
Catecholamines with reduction properties can be oxidized
in either water or buﬀer solution. This property has been
previously applied in methods based on the electrochemical
analysis of dopamine.21–23 Inspired by this detection approach,
we report a novel design strategy for the preparation of fluorescent
sensors for the detection of L-DOPA. To the best of our knowledge,
this is the first fluorescent sensor for L-DOPA based on a redox
reaction. To demonstrate the application of this redox reactive
approach, we employed a resazurin dye as our signal reporter
not only due to its sensitive and simple mechanism of action, but
also due to its unique oxidative and electron dependent optical
properties.24 Our previous work has also shown that resazurin-based
dyes can be utilized in redox reaction based sensors.25
Scheme 1 indicates the structures of the fluorescent sensors
investigated in this study and the proposed sensing approach.
Resazurin-based sensors (Resa-Sulf and Resa-Con) are shown as
self-quenching fluorophores, however, upon addition of L-DOPA,
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a redox reaction occurs and L-DOPA as the reductant reduces the
weakly fluorescent resazurin fluorophore, leading to deoxygena-
tion of the N-oxide group, producing the resultant resorufin
structures as strongly fluorescent products. The synthesis of
these sensors is described in Fig. S1 (ESI†), and all sensors were
fully characterized by 1H NMR, 13C NMR and HRMS (shown in
the ESI†).
To obtain the optimum sensing conditions, the fluorescence
response of Resa-Con to diﬀerent analytes as functions of time and
pH was systematically studied in DMSO/PBS buﬀer solution (v/v =
1 :1). As shown in Fig. S2 (ESI†), Resa-Con is almost non-fluorescent
over a large pH range from 4.3 to 11.2. Upon treatment with L-DOPA,
as well as other catecholamines, the fluorescence is enhanced.
Furthermore, the fluorescence enhancement is greater in weakly
basic solutions compared to under acidic conditions. By evaluating
the reaction rate, upon addition of analytes at pH 11.2, the fluores-
cence is almost saturated within 3 min of analyte addition, and a
color change from red to yellow is observed. This makes it possible
to detect L-DOPA via the naked eye or under irradiation using a UV
lamp. These results are consistent with a previous study which
shows that the absorption and fluorescence properties of resazurin
and resorufin are dependent on pH, and that the fluorescence is
enhanced at higher pH.19 Unfortunately, under these conditions,
Resa-Con does not show perfect selectivity towards other catechol-
amines, such as dopamine, epinephrine and norepinephrine. This
result is not surprising, because these three types of catecholamines
share similar functional groups.26–28
In order to reduce the fraction of DMSO in the sensing system,
we prepared Resa-Sulf to improve aqueous solubility. By comparing
the fluorescence responses of Resa-Con and Resa-Sulf towards
L-DOPA, we found that with 50% DMSO as a co-solvent, the
maximum fluorescence intensities of the two sensors were
essentially the same in the presence of L-DOPA; however, in
1% DMSO/PBS buﬀer, the highest fluorescence intensity of the
water-soluble fluorescent sensor, Resa-Sulf, is almost 7 times
that of non-water-soluble Resa-Con after 2 min of incubation.
This provides higher sensitivity and a larger response range in
the aqueous environment (Fig. S3, ESI†). Clearly, aggregation of
Resa-Con was observed in 1% DMSO/PBS buﬀer (Fig. S4, ESI†).
Considering the fast response and high sensitivity between
Resa-Sulf and L-DOPA, 1%DMSO/PBS buﬀer at pH 11.2 was selected
as the sensing solvent for further experiments. Subsequently, the
time-dependent fluorescence changes of Resa-Sulf (50 mM) in the
presence of L-DOPA (0–100 mM) were investigated. This experiment
showed that the enhanced fluorescence intensity saturates
within nearly 2 minutes of incubation (Fig. S5, ESI†).
Encouraged by the fast response, we then tested the reactivity of
Resa-Sulf upon addition of L-DOPA in PBS with an incubation time
of 2 min. The spectral changes of Resa-Sulf during the titration with
L-DOPA are shown in Fig. 1. Upon addition of increasing concentra-
tions of L-DOPA, the maximum absorption band changed from
530 nm to 480 nm, meanwhile, the fluorescence band centered at
615 nm blue-shifts to 580 nm, which results from the redox reaction
betweenResa-Sulf and L-DOPA (movie, ESI†). Pleasingly, the changes
in fluorescence intensities of Resa-Sulf (50 mM) showed a linear
calibration response to L-DOPA concentrations from 0 to 50 mMwith
the coeﬃcient of determination R2 = 0.9997 (Fig. 1C). Furthermore,
to test the sensitivity ofResa-Sulf, similar fluorescence titrations were
performed with Resa-Sulf at 1 mM, and the fluorescence response to
L-DOPA also showed a good linear relationship (R2 = 0.9926) even at
very low L-DOPA concentrations ranging from 0 to 0.8 mM (Fig. 1D).
Notably, the detectable concentration of L-DOPA can be as low as
0.01 mM. More importantly, as one of the advantages of redox
reaction based sensing, the ratio of the sensor to analyte can be
easily identified based on the nature of the redox reaction. As
expected, the fluorescence of Resa-Sulf (20 mM) increased to the
maximum level at a concentration of L-DOPA of 20 mM in 10 min,
which suggests that the ratio between Resa-Sulf and L-DOPA is 1 :1
(Fig. S6, ESI†). Furthermore, Job’s plot analysis also confirmed a 1 :1
reaction stoichiometry (Fig. S7, ESI†).29 The fast response and the
clear reaction ratio suggest that Resa-Sulf has good potential for
application in the quantitative detection of L-DOPA concentrations.
In order to examine the selectivity of Resa-Sulf towards
L-DOPA, the fluorescence changes of Resa-Sulf in the presence
of diﬀerent redox reagents, such as NADH, catechol and amino
acids, were examined by monitoring the changes of the peak
maxima at 570 nm. With the exception of dopamine, epinephrine
Scheme 1 The structures of fluorescent sensors and the proposed sensing
mechanism of L-DOPA.
Fig. 1 (A) UV-Vis absorption and (B) fluorescence spectra of Resa-Sulf
(50 mM) during the titration with increasing concentrations of L-DOPA
(0–50 mM). Inset: (A) The color and (B) fluorescence images of Resa-Sulf
(50 mM) in the absence and presence of L-DOPA (50 mM). Incubation time:
2 min. (C) Plot of the fluorescence intensity of Resa-Sulf (50 mM) at 570 nm
against the concentrations of L-DOPA from 0 to 50 mM. Incubation time:
2 min. (D) Plot of the fluorescence intensity of Resa-Sulf (1 mM) at 570 nm
against the concentrations of L-DOPA from 0 to 0.8 mM. Incubation time:
2 min. lex = 480 nm, 25 1C.
Communication ChemComm
Pu
bl
ish
ed
 o
n 
27
 O
ct
ob
er
 2
01
7.
 D
ow
nl
oa
de
d 
by
 P
O
ST
EC
H
 L
ib
ra
ry
 o
n 
6/
19
/2
01
9 
6:
41
:3
7 
A
M
. 
View Article Online
This journal is©The Royal Society of Chemistry 2017 Chem. Commun., 2017, 53, 12465--12468 | 12467
and norepinephrine, which share similar structures with L-DOPA,
all other species showed no response to Resa-Sulf. Upon addition
of an equivalent amount of L-DOPA to each competitive species,
the fluorescence enhancement is recovered (Fig. 2). In particular,
Resa-Sulf does not respond to catechol, probably due to the
diﬀerences in the electrochemical properties to catecholamines.
These results indicated that Resa-Sulf has relatively good selectivity
for L-DOPA and catecholamines over other biologically relevant
redox regents. Therefore, Resa-Sulf shows potential application in
L-DOPA analysis in the absence of catecholamines. It should be
noted that only in the presence of dopamine is a similar fluores-
cence response observed: epinephrine and norepinephrine give
small fluorescencemaxima compared to in the presence of L-DOPA.
The reaction rate constants are shown in Fig. S8 (ESI†). Considering
the complexity of the intracellular environment, it is diﬃcult to use
this probe for neurotransmitter imaging by simple incubation;
however, it still has high potential for cell imaging if the probe
can be delivered into specific organelles in neuronal cells.30
To obtain more detailed insights into the sensing mechanism,
HPLC-MS was employed to characterize the reaction between
Resa-Sulf and L-DOPA.31 The Resa-Sulf samples were injected for
HPLC before and after 2 min of incubation of L-DOPA. The results
from this HPLC-MS test showed that the signal corresponding to
Resa-Sulf at 8.1 min disappeared and a new peak corresponding to
the reduction product Reso-Sulf at 8.5 min emerged (Fig. 3). The
results were further confirmed by mass spectral analysis. The signal
at 8.1 min shows characteristic mass information for Resa-Sulf,
while the new peak at 8.5 min shows mass information for the
reduction product Reso-Sulf (Fig. S9, ESI†).
To further confirm the proposed sensing mechanism, the
reaction of Resa-Sulf with L-DOPA was also analyzed by 1H NMR
spectroscopy. As shown in Fig. 4, upon the addition of L-DOPA,
the major peaks of Resa-Sulf ranging from 6 ppm to 8 ppm
disappeared, while new peaks corresponding to the Reso-Sulf
product clearly emerged. In particular, the two doublets at 8.02 ppm
and 7.98 ppm which correspond to the proton resonances on either
side of the N-oxide group undergo a large upfield shift to 7.55 ppm
and 7.38 ppm respectively in the reduced species due to the loss of
deshielding eﬀects. Furthermore, Reso-Sulf was successfully isolated
and fully characterized in high yield after the reaction of Resa-Sulf
with L-DOPA (see the ESI† for synthesis and characterization). Taken
together, these results clearly confirm the reductive sensing
mechanism of L-DOPA with Resa-Sulf.
Our goal is to develop a simple and reliable sensing method
for the quantitative detection of L-DOPA in real samples. Many
health care products containing L-DOPA are sold as mood
enhancers or to improve stress responses, and also as drugs for
the treatment of Parkinson’s disease and dopamine-responsive
dystonia; however, overuse of L-DOPAmay cause serious side eﬀects,
such as nausea, vomiting, strong headaches, and disruption of sleep
cycles.5,32 In order to quantitatively detect L-DOPA concentrations,
we applied Resa-Sulf to analyse L-DOPA in real samples. Standard
calibration curves were developed using fluorescence and HPLC
methods with known, diﬀerent concentrations of pure L-DOPA
(Fig. S10 and S11, ESI†).33 By comparing the actual L-DOPA amount
acquired from HPLC and fluorescence measurements, we found
that the calculated data for L-DOPA from diﬀerent methods
correlated very well, thus confirming that Resa-Sulf is feasible
for practical determination of L-DOPA in real samples. A com-
mercially available source, DOPA Mucuna Veg Capsules, was
purchased from Now Foods and used without further treatment.
The DOPA capsule was dissolved and diluted before analysis by
treatment with Resa-Sulf. Table 1 shows that Resa-Sulf can be
used to determine the concentration of L-DOPA in commercial
Fig. 2 Fluorescence responses of Resa-Sulf (20 mM) upon addition of
various relevant redox regents. Incubation time: 5 min; analytes (50 mM):
(1) PBS buﬀer; (2) NADPH; (3) NADH; (4) NAD+; (5) ATP; (6) Met; (7) Cys;
(8) Tyr; (9) phenol; (10) catechol; (11) glucose; (12) GSH; (13) Na+; (14) K+;
(15) Cl; (16) dopamine; (17) epinephrine; and (18) norepinephrine. The light
gray bar represents the fluorescence intensity of only a single analyte with
Resa-Sulf; the dark gray bar represents the fluorescence intensity of the
analyte and L-DOPA with Resa-Sulf. lex = 480 nm, lem = 570 nm, 25 1C.
Fig. 3 HPLC-MS spectral changes observed for Resa-Sulf (100 mM) upon
addition of L-DOPA (500 mM). The absorbance signals were collected at
500 nm.
Fig. 4 Partial 1H NMR spectra showing the reaction of Resa-Sulf (10 mM)
and L-DOPA (20 mM) in D2O. (A) The proposed sensing mechanism with
proton assignment. (B) Resa-Sulf only. (C) Resa-Sulf and L-DOPA in the
middle of the reaction. (D) Resa-Sulf and L-DOPA after completion of the
reaction.
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samples with good recovery. The level of L-DOPAwas calculated to be
13.09% and 12.85% based on Resa-Sulf and HPLC measurements
respectively (Fig. S12, ESI†), which agrees well with the content
declared by the company (15%). Thus, Resa-Sulf can be utilized
as a simple tool to accurately quantify L-DOPA concentrations in
commercially available health care products or L-DOPA containing
plants.
In summary, by exploiting the reductive properties of L-DOPA,
we have found a simple, rapid turn-on sensor for the quantitative
detection of L-DOPA for the first time. The water-soluble sensor
Resa-Sulf shows high selectivity and fast response towards L-DOPA,
and the nature of the redox reaction makes it a good, practical
tool for the quantitative detection of L-DOPA in real samples.
This approach was successfully applied in the detection of a
commercially available source of L-DOPA with a simple operation
process. HPLC-MS and 1H NMR studies provided a strong support
for the mechanism of L-DOPA detection by Resa-Sulf. Therefore,
this new approach not only provides an eﬃcient tool for L-DOPA
detection, but also oﬀers a novel design strategy for the future
development of other catecholamines sensors.
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